Visudyne

DRUG6 trials

Conditions

Age Related Macular DegenerationAge-Related Macular DegenerationMacular DegenerationNeovascular Macular DegenerationRetinal Vascular DisordersVertebral Metastases

Phase 1

Photodynamic Therapy for the Treatment of Vertebral Metastases

CompletedNCT02464761

Sunnybrook Health Sciences CentreVertebral Metastases

Start: 2011-06-30End: 2017-09-07Updated: 2018-02-15

Phase 2

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration

CompletedNCT00140803

Manhattan Eye, Ear & Throat HospitalAge-Related Macular Degeneration

Start: 2003-10-31End: 2007-01-31Updated: 2007-07-12

Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself

WithdrawnNCT00457678

Vitreous -Retina- Macula Consultants of New YorkAge Related Macular Degeneration

Start: 2007-01-31End: 2007-12-04Updated: 2017-08-23

Phase 3

VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)

CompletedNCT01482910

BayerMacular Degeneration

Start: 2011-12-31End: 2014-08-31Updated: 2016-11-04

Phase 4

Aflibercept in Polypoidal Choroidal Vasculopathy

CompletedNCT02120950

BayerNeovascular Macular Degeneration

Start: 2014-05-29End: 2017-07-07Updated: 2020-12-02

Unknown Phase

ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study

NCT01974622

Manhattan Eye, Ear & Throat HospitalRetinal Vascular Disorders

Start: 2013-04-30End: 2015-06-30Target: 30Updated: 2013-11-01

Related Papers

Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study

JAMA Ophthalmology2018-05-03253 citations

Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study

Journal of Ocular Pharmacology and Therapeutics2017-05-176 citations